Actively Recruiting
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Led by Boston Children's Hospital · Updated on 2025-12-05
60
Participants Needed
3
Research Sites
53 weeks
Total Duration
On this page
Sponsors
B
Boston Children's Hospital
Lead Sponsor
C
Cystic Fibrosis Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).
CONDITIONS
Official Title
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with CF
- 18 or more years of age
- Prescribed CFTR modulator therapy to be taken twice daily
- Can speak and read English
- Have regular access to an iOS or Android tablet or smartphone with internet access
You will not qualify if you...
- Any situation that, in the opinion of the Investigator, would compromise patient safety or data quality
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University of Alabama-Birmingham
Birmingham, Alabama, United States, 35233
Not Yet Recruiting
2
Johns Hopkins University
Baltimore, Maryland, United States, 21218
Not Yet Recruiting
3
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
E
Emma M McWilliams, BA
CONTACT
C
Callie Bacon, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here